Hemp Industries Association and RE Botanicals Inc. are barred from bringing a challenge in federal district court against Drug Enforcement Administration regulations concerning the possession and manufacture of hemp byproducts, the D.C. Circuit affirmed.
Only appeals courts may hear challenges to DEA determinations, findings, and conclusions under the Controlled Substances Act, Judge Karen LeCraft Henderson of the US Court of Appeals for the D.C. Circuit ruled June 10.
The DEA in August 2020 issued a rule meant to conform existing regulations to amendments to the CSA in its treatment of hemp.
HIA and RE Botanicals—a trade association and a seller …